Financials
- Market Capitalization 1.89 B
- Employee 524
- Founded 2008
- CEO Bahija Jallal
- Website www.immunocore.com
- Headquarter United Kingdom
- FIGI BBG00YYCXFB9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-48.89
ratio cours/chiffre d'affaires
4.37
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | XNCR Xencor, Inc. - Common Stock | 26.02 USD | -9.90% | -6.40% | +30.56% | +221.23% | 1.93 B USD | ||
| 2051 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.78 USD | -3.02% | -5.09% | +6.84% | +103.52% | 1.88 B USD | ||
| 2061 | VIR Vir Biotechnology, Inc. - Common Stock | 10.84 USD | -4.16% | +10.84% | +22.62% | +81.27% | 1.83 B USD | ||
| 2070 | SEPN Septerna, Inc. - Common Stock | 38.92 USD | -3.83% | -4.40% | +14.57% | +76.83% | 1.82 B USD |